Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.

Codarri L, Greter M, Becher B.

Trends Immunol. 2013 Mar;34(3):114-9. doi: 10.1016/j.it.2012.09.007. Epub 2012 Oct 29. Review.

PMID:
23116549
3.

Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.

Kruglov AA, Lampropoulou V, Fillatreau S, Nedospasov SA.

J Immunol. 2011 Dec 1;187(11):5660-70. doi: 10.4049/jimmunol.1100663. Epub 2011 Nov 4.

4.
5.

Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.

Moliné-Velázquez V, Cuervo H, Vila-Del Sol V, Ortega MC, Clemente D, de Castro F.

Brain Pathol. 2011 Nov;21(6):678-91. doi: 10.1111/j.1750-3639.2011.00495.x. Epub 2011 Jun 9.

PMID:
21507122
6.

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.

Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H.

Nat Med. 2003 Mar;9(3):287-93. Epub 2003 Feb 24.

PMID:
12598893
7.

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH.

Clin Exp Immunol. 2010 Oct;162(1):1-11. doi: 10.1111/j.1365-2249.2010.04143.x. Review.

8.
9.

Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C.

J Exp Med. 2006 Feb 20;203(2):425-35. Epub 2006 Feb 13.

10.

[Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].

Rodríguez-Rodríguez Y, Suárez-Luis I.

Rev Neurol. 2003 Apr 1-15;36(7):649-52. Review. Spanish.

11.

GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.

Croxford AL, Spath S, Becher B.

Trends Immunol. 2015 Oct;36(10):651-662. doi: 10.1016/j.it.2015.08.004. Review.

PMID:
26431942
12.
13.

CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis.

Liu JQ, Carl JW Jr, Joshi PS, RayChaudhury A, Pu XA, Shi FD, Bai XF.

J Immunol. 2007 May 15;178(10):6227-35.

14.

Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.

Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.

Glia. 2005 Aug 15;51(3):235-40.

PMID:
15812814
15.

Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.

Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.

Brain. 2012 May;135(Pt 5):1586-605. doi: 10.1093/brain/aws058. Epub 2012 Mar 24.

PMID:
22447120
16.
17.
18.

Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid.

Schläger C, Körner H, Krueger M, Vidoli S, Haberl M, Mielke D, Brylla E, Issekutz T, Cabañas C, Nelson PJ, Ziemssen T, Rohde V, Bechmann I, Lodygin D, Odoardi F, Flügel A.

Nature. 2016 Feb 18;530(7590):349-53. doi: 10.1038/nature16939. Epub 2016 Feb 10.

PMID:
26863192
19.

T-cells in multiple sclerosis.

Severson C, Hafler DA.

Results Probl Cell Differ. 2010;51:75-98. doi: 10.1007/400_2009_12. Review.

PMID:
19582415
20.

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.

Ann Neurol. 2009 Sep;66(3):310-22. doi: 10.1002/ana.21719.

PMID:
19798635

Supplemental Content

Support Center